I asked Grok about Sun Pharma's US Manufacturing footprint. It said "Sun Pharma has a modest but strategic manufacturing footprint in the United States, focused mainly on finished dose formulations, sterile injectables/radiopharmaceuticals, and active pharmaceutical ingredients (APIs). Most of its global manufacturing (the majority of its ~40–43 facilities) remains in India". Is this a US tariff issue?
An interesting tidbit is that their US headquarters are in Princeton New Jersey. Hmm, who else has their mysterious "commercial' headquarters there? Sun Pharma has a small rare disease program as well.
Lots of possibilities out there, Let's get on with it.
Market Data 
Markets 
AI
